Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,143 public trials 560 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

National Liver Cancer Screening Trial

NCT06084234

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +22 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • Kaiser Permanente Roseville, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 19 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 67 locations
View Trial Details
Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

NCT06915753

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +23 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion San Francisco, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
View all 16 locations
View Trial Details
Recruiting

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

NCT07219459

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Peidmont Healthcare, Inc Atlanta, Georgia, United States
  • OSF St. Francis Medical Center Peoria, Illinois, United States
  • Hannover Medical School Hanover, Lower Saxony, Germany
View all 23 locations
View Trial Details

Related conditions